1 killed, 6 injured in gas cylinder blast in Pakistan's Karachi
Darpan News Desk IANS, 17 Nov, 2021 12:51 PM
Islamabad, Nov 17 (IANS) One person was killed and six including children were injured in a gas cylinder explosion in Pakistan's southern port city of Karachi on Wednesday, the police said.
The incident happened inside a multi-storeyed building in Lyari area of Karachi, the provincial capital of southern Sindh province, police officials told local media.
The residential building was also partially damaged due to the cylinder blast, said the police, adding that it might have happened due to a gas leak, Xinhua news agency reported.
The injured people have been shifted to a nearby hospital and are being treated for severe burn injuries.
Local authorities have conducted investigations after New York University (NYU) evacuated multiple buildings due to bomb threats. The locations were soon evacuated, according to the university. Police conducted a search and later issued an all clear, reports Xinhua news agency.
International flight arrivals are expected to rise 11 per cent on Monday over a similar day in October at Newark Liberty and John F. Kennedy international airports, with 253 flights scheduled to arrive, according to the Port Authority of New York and New Jersey, Xinhua news agency reported.
Paramhans Desai, 38, was shot when he arrived at a house in McDonough in Georgia state on the evening of November 4 as he tried to make an arrest, local county Sheriff Reginald Scandrett said at a news conference. The attacker pulled away and drew a handgun and shot Desai before fleeing in a car, Scandrett said.
Along Canada's boundary, cross-border hockey rivalries were upended. Churches that had members on both sides of the border were suddenly cut off from each other.
Available in a range of standards, including gold and silver, the special collectors' coin was designed by Heena Glover and features an image of a lotus, India's national flower, alongside one of Gandhi's most famous quotes -- "My life is my message".
The pill was licensed for adults 18 and older who have tested positive for COVID-19 and have at least one risk factor for developing severe disease, such as obesity or heart disease. Patients with mild-to-moderate COVID-19 would take four pills of the drug, known molnupiravir, twice a day for five days.
